Trials / Recruiting
RecruitingNCT05514327
A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL
the Safety and Efficacy of Ultra-fraction Radiotherapy Bridging CART Cell Therapy in Relapsed/Refractory Diffuse Large b Cell Lymphoma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-arm single center study to prospectively evaluate the safety and efficacy of ultra-fraction radiotherapy bridging CAR-T therapy in relapsed/refractory diffuse large b cell lymphoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | ultra-fraction radiotherapy | the R/R DLBCL patients would receive ultra-fraction radiotherapy as bridging therapy before the CD19 CART cell infusion |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2027-09-01
- Completion
- 2028-12-01
- First posted
- 2022-08-24
- Last updated
- 2026-03-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05514327. Inclusion in this directory is not an endorsement.